Balyasny Asset Management »

Akero Therapeutics shares owned by Balyasny Asset Management

Quarter-by-quarter ownership of Akero Therapeutics (AKRO) shares owned by Balyasny Asset Management from 13F filings

Historical chart of Balyasny Asset Management investment in Akero Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Akero Therapeutics held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akero Therapeutics by Balyasny Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $4.6M 198k 23.35
2023-09-30 $2.0M 39k 50.58
2023-06-30 $3.6M 78k 46.69

More positions owned by Balyasny Asset Management

Ishares Tr Russell 2000 Etf (IWM)
Microsoft Corporation Call Option (MSFT)
Apple (AAPL)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Select Sector Spdr Tr Financial (XLF)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Hess Put Option (HES)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Amazon (AMZN)
JPMorgan Chase & Co. Call Option (JPM)
Ishares Tr Core S&p Mcp Etf (IJH)
Union Pacific Corporation Call Option (UNP)
Select Sector Spdr Tr Technology (XLK)
Boeing Company (BA)
Deere & Company (DE)

View all positions for Balyasny Asset Management

Top funds holding Akero Therapeutics

Henderson Group
T. Rowe Price Associates
Vanguard Group
Wellington Management Company
Baker Bros. Advisors
Yiheng Capital
Boxer Capital
Alliancebernstein
Redmile Group
Perceptive Advisors
Logos Global Management
Point72 Asset Management
Citadel Advisors
Goldman Sachs Group
Holocene Advisors

View all funds holding Akero Therapeutics